Table 3.
Reliability of outcomes measured during the experimental protocol.
| Trial 1 | Trial 2 | Effect size (90% CI) | TE (90% CI) | ICC (90% CI) | CV | |
|---|---|---|---|---|---|---|
| SJ (cm) | 39.5 ± 4.1 | 35.8 ± 5 | 0.81 (90% CI = −0.09 to 1.62) | 2.51 (90% CI = −1.77 to 4.50) | 0.78 (90% CI = 0.20 to 0.91) | 9.6% |
| CMJ (cm) | 39.2 ± 4.3 | 37.5 ± 3.8 | 0.39 (90% CI = −0.46 to 1.20) | 1.0 (90% CI = −0.05 to 2.39) | 0.80 (90% CI = 0.3 to 1) | 9.5% |
| MVC (N) | 733 ± 119.1 | 823.8 ± 101.4 | 0.14 (90% CI = −0.2 to 0.09) | 6.2 (90% CI = −12.1 to 31. 9) | 0.75 (90% CI = 0.03 to 0.98) | 8.6% |
| SP (s) | 3.1 ± 0.1 | 3.2 ± 0.2 | −0.63 (90% CI = −1.44 to 0.24) | 0.16 (90% CI = −0.11 to 0.28) | 0.67 (90% CI = −0.1 to 0.81) | 12.2% |
Trial 1 and trial 2 are respectively the baseline values of the two conditions. CV, coefficient of variation. ICC, intraclass correlation coefficient; CI, 90% confidence intervals; TE, typical error.
SJ, Squat jump; CMJ, countermovement jump; MVC, maximal voluntary contraction; SP, 20 m sprint test.